CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net Income (Loss)	$ (2,387)	$ (5,397)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	329	195
Stock-based compensation expense	598	658
Credit loss, net of recoveries	496	725
Gain on disposition of assets	(2)	(10)
Noncash amortization of debt discount	136	136
Noncash change in fair value of derivatives	(14)	(267)
Other	1	3
Changes in operating assets and liabilities:
Accounts receivable	(13)	(1,065)
Prepaid expenses and other current assets	266	(2,460)
Accounts payable	(173)	(401)
Accrued expenses and other current liabilities	(223)	(1,565)
Deferred revenue	113	222
Net cash used in operating activities	(873)	(9,226)
Cash flows from investing activities
Additions of property, equipment, and software	(211)	(535)
Proceeds from sale of property and equipment	2	10
Net cash used in investing activities	(209)	(525)
Cash flows from financing activities
Issuance of common Stock under ESPP	16	120
Tax payments related to shares retired for vested restricted stock units	(40)	0
Repayments of related party payables	(90)	(8)
Net cash (used in) provided by financing activities	(114)	112
Net decrease in cash, cash equivalents, and restricted cash	(1,196)	(9,639)
Cash, cash equivalents, and restricted cash, beginning of period	15,544	25,202
Cash, cash equivalents, and restricted cash, end of period	14,348	15,563
Supplemental disclosure of non-cash financing activities
Short-term financing of insurance payable	$ 1,399	$ 0